Aspire Biopharma Holdings, Inc.

Brings total authorized repurchase to $10 million Reflects leadership's view that Aspire-Lakewood's share price does not reflect the Company's financial strength or long-term growth opportunity Increased authorization supported by strength of newly acquired Dura Control Systems Corp's (DCSC) full year 2025 and six months ended June 30, 2026 revenue of approximately $209.5 million and Adjusted EBITDA 1 of $22.3 million and approximately $103.9 million and Adjusted EBITDA 1 of $10.5... The post Aspire-Lakewood Holdings Board Approves $10 Million Share Repurchase Program appeared first on Aspire Biopharma, Inc..

ESTERO, FL / ACCESS Newswire / September 8, 2026 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP) ("Aspire" or the "Company"), today announced that it has changed its corporate name from "Aspire Biopharma Holdings, Inc." to "Aspire-Lakewood Holdings, Inc." The name change is effective upon the filing of a Certificate of Amendment to the Company's Certificate of Incorporation with the Secretary of State of the State of Delaware. The Company's ticker symbol, "ASBP", will remain unchanged. Kr... The post Aspire Biopharma Holdings, INC. Announces Corporate Name Change To Aspire-Lakewood Holdings, Inc. appeared first on Aspire Biopharma, Inc..

ESTERO, FL / ACCESS Newswire / August 13, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), today announced that management will be present and host one-on-one meetings with investors at Sidoti & Company's Micro-Cap Virtual Investor Conference taking place on August 19-20, 2026. Management plans to discuss its clinical and commercial development pipeline and its recently closed acquisition of Dura Driver Control Systems, a leading global automotive supp... The post Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th appeared first on Aspire Biopharma, Inc..

Acquisition represents a transformative milestone for Aspire, positioning the Company to rapidly evolve into a diversified, high-revenue enterprise Adds an established global brand with scale in large and growing markets driven by trends in vehicle and mobility control systems Augments revenue growth profile and diversifies Aspires' development and commercial portfolio with new high growth business Expected to immediately improve path to profitability ESTERO, FL / ... The post Aspire Biopharma Completes Acquisition of Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue appeared first on Aspire Biopharma, Inc..

High-Octane Partnership: Multi-time X Games medalist Jarryd McNeil joins BUZZ BOMB™ to fuel brand expansion in action sports. Consumer Connection: The collaboration strengthens BUZZ BOMB™'s commitment to delivering fast-acting energy to elite athletes and active consumers worldwide. ESTERO, FL / ACCESS Newswire / July 20, 2026 / Aspire Biopharma Holdings, Inc.'s (NASDAQ:ASBP) ("Aspire" or the "Company") wholly owned subsidiary Buzz Bomb Caffeine Company LC annou... The post Freestyle Motocross Legend Jarryd McNeil Named Newest Sponsored Athlete for Aspire Biopharma’s BUZZ BOMB(TM) appeared first on Aspire Biopharma, Inc..

NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the presentations from the June 24 th & 25 th Life Sciences Virtual Investor Forum are now available for on-demand viewing. REGISTER AND VIEW PRESENTATIONS HERE Select companies are accepting 1x1 management meeting requests through June 19 th . Please Schedule 1x1 Meetings here . The presentations will be available 24/7 for 90 days. I... The post Life Sciences Virtual Investor Forum Presentations Now Available for On-Demand Viewing appeared first on Aspire Biopharma, Inc..

The brand expands nationwide distribution on Amazon, delivering a waterless, rapid-dissolve 50 mg caffeine powder built for active, on-the-go lifestyles. ESTERO, FL / ACCESS Newswire / June 24, 2026 / Aspire Biopharma Holdings, Inc.'s (Nasdaq:ASBP) ("Aspire" or the "Company") wholly owned subsidiary Buzz Bomb Caffeine Company LC today announced the nationwide Amazon launch of its innovative BUZZ BOMB ™ 50mg caffeine stick packs. This e-commerce expansion represents a sig... The post Aspire Biopharma’s BUZZ BOMB(TM) Launches on Amazon, Introducing Next-Generation Caffeine Stick Packs appeared first on Aspire Biopharma, Inc..

NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- Virtual Investor Conferences, the leading proprietary investor conference series, today announced the agenda for the Life Sciences Virtual Investor Forum, taking place June 24 th & 25 th , 2026. Individual investors, institutional investors, advisors, and analysts are invited to attend. REGISTER HERE Investors are encouraged to pre-register and run the online system check to expedite participation and receive event updates. Participat... The post Life Sciences Virtual Investor Forum Agenda Announced for June 24th & 25th appeared first on Aspire Biopharma, Inc..

ESTERO, Fla., June 17, 2026 (GLOBE NEWSWIRE) -- Aspire Biopharma Holdings, Inc.’s (Nasdaq: ASBP) (“Aspire” or the “Company”), today announced that it will present live at the Life Sciences Investor Forum hosted by VirtualInvestorConferences.com on June 25 th , 2026. DATE : June 25 th    TIME: 2:00 pm ET REGISTER HERE Available for 1x1 meetings: June 24-25. Schedule 1x1 Meetings here . The event will be conducted as a live, inter... The post Aspire Biopharma to Present at the Life Sciences Investor Forum on June 25th appeared first on Aspire Biopharma, Inc..

Adds an established global brand with scale in large and growing markets driven by trends in vehicle and mobility control systems Acquisition significantly accelerates Aspire's revenue, earnings growth and cash flow profile Strategically diversifies Aspire's revenue streams Opportunity to drive significant shareholder value creation and enhance long-term capital allocation optionality Company does not anticipate procuring new equity financing to consummate the tran... The post Aspire Biopharma Announces Signing of Definitive Share Purchase Agreement to Acquire Dura Driver Control Systems, a Leading Global Automotive Supplier with a 100+ Year History and $200M+ in 2025 Revenue appeared first on Aspire Biopharma, Inc..